• Hong Kong’s Rich Are Preparing for a Worst-Case Scenario

    Hong Kong’s Rich Are Preparing for a Worst-Case ScenarioJun.14 — Hong Kong seems to have avoided a wave of capital outflows that many feared after Beijing moved to impose a national security law on the city, but there is still growing anecdotal evidence that the city’s rich are increasingly hedging their bets by opening offshore bank accounts and applying for alternative passports. Bloomberg’s Eric Lam reports on “Bloomberg Markets: China Open.”

    from Yahoo Finance https://ift.tt/2MXiK2f

  • Healius share price soars 20% on news of $500 million sale

    The Healius Ltd (ASX: HLS) share price is up by 20.36% at the time of writing, following a market update this morning announcing the sale of its medical centres. 

    What’s moving the Healius share price?

    The company announced the sale of Healius Primary Care, its medical centres business, to BGH Capital for $500 million. The proceeds will be used for investments and to pay down debt.

    Commenting on the sale, Healius managing director and CEO, Dr Malcolm Parmenter said:

    This sale is consistent with our strategy of simplifying our portfolio and focusing on our leading and scalable diagnostics and day hospital business, in order to deliver on our mission of seeking and sustaining life-enhancing healthcare through people who care.

    The proceeds will strengthen the company, reducing our net debt and freeing up capital for investment, while enabling shareholders to realise the value of the Medical Centres business, which has not been reflected in our share price.

    Healius expects to receive a total of $470 million from the sale after costs. The transaction is expected to be completed by the end of 2020 and will be subject to approval by the foreign investment review board.

    The company also announced that it has seen growth in its diagnostics business since the economy started to reopen following shutdowns. This has been supported by testing for the coronavirus in its pathology labs. Healius announced that its day hospitals, dental and IVF businesses were also moving back toward pre-coronavirus levels following the lifting of restrictions.

    How has the Healius share price performed in 2020?

    The Healius share price is up 58.33% since its 52-week low reached in April. The company’s share price performance for the year to date has been steady, rising 10.14% since the beginning of January. The Healius share price has fallen 4.10% since this time in 2019, but is now significantly closer to its 52-week high of $3.32. 

    Looking for shares to help you grow your wealth? Don’t miss the free report below.

    3 “Double Down” Stocks To Ride The Bull Market

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon three under-the-radar stock picks he believes could be some of the greatest discoveries of his investing career.

    He’s so confident in their future prospects that he has issued “double down” buy alerts on each of these three stocks to members of his Motley Fool Extreme Opportunities stock picking service.

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor Chris Chitty has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Healius share price soars 20% on news of $500 million sale appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2N0Ad9M

  • What Sony Analysts Like About The PlayStation 5 Presentation

    What Sony Analysts Like About The PlayStation 5 PresentationSony Interactive Entertainment (NYSE: SNE) unveiled its next-gen PlayStation 5 console Thursday along with an impressive line of games.Both exclusive and third-party titles were highlighted during "The Future of Gaming" event. The responses to the PS5 have been positive, a good sign considering that a price point for both consoles have not been revealed.Primary, Digital PlayStation Console Could Boost Sales: The presentation primarily focused on the lineup of games for the PS5, but Sony also revealed two versions of the next-gen console: the PS5 and the PS5 Digital Edition. "We were somewhat surprised that Sony announced a digital version of the PS5 without an optical drive, in addition to the traditional model with an optical drive," BofA Securities analyst Mikio Hirakawa wrote in a note. BofA believes the market consensus estimate for the PS5 hardware price is $499. The addition of the digital console is expected to help boost sales by launching with a price cheaper than the primary PS5.See Also: Sony Finally Reveals What The Playstation 5 Looks LikeMorgan Stanley sees the console as likely to be priced high, targeting "hardcore users," analyst Masahiro Ono said in a note. Factors such as the design of the hardware as well as the "near life-like images offered" in-game will boost prices, the analyst said.The added value could give room for Sony to take a risk with premium prices, especially with the addition of the digital version of the PS5. Key Titles Help Push Excitement: The first presentation of the PS5 showcased 26 new titles in a mixture of first-party exclusives and third-party additions. Among those, titles like "Spider-Man: Miles Morales" will seemingly coincide with the PlayStation 5's launch. This will help motivate day-one purchases. BofA Securities analysts believe the PS5's software lineup meets expectations.Morgan Stanley analysts "do not expect the market's view on initial sales expectation to change sharply." Special attention was given to titles like "Spider-Man: Miles Morales" and "Horizon Forbidden West," the only two sequels to "popular PS4 titles that ranked within the top 20 in cumulative copies sold."Sony Analyst RatingsBofA Securities maintains a Buy rating with an $80.24 price objective. Morgan Stanley maintains an Equal-weight rating.Latest Ratings for SNE DateFirmActionFromTo Mar 2020OppenheimerInitiates Coverage OnOutperform Oct 2019Gabelli & Co.Initiates Coverage OnBuy Mar 2019JefferiesDowngradesBuyHold View More Analyst Ratings for SNE View the Latest Analyst RatingsSee more from Benzinga * GTA Online As A Standalone PS5 Title Could Be More Important Than You Think * 'Spider-Man: Miles Morales' Confirmed To Be Standalone Title(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/30EmaPi

  • U.S. health secretary expresses confidence in Abbott’s fast COVID-19 test

  • The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO

  • Mesa Air Group, Inc. Just Missed EPS By 41%: Here’s What Analysts Think Will Happen Next

  • Novavax, Inc. (NASDAQ:NVAX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates